BioGraph 55, Inc. is a San Francisco based early-stage target discovery and drug development biotech company focused on immuno-oncology. The company leverages a proprietary and scientifically validated (through external partners) spatial-mapping technology platform called SPARTA (Spatial Processing And Regional Tissue Analysis) that collects biological information from cellular interactions and integrates this information with genomic/transcriptomic data to identify novel drug targets. Our first program aims to develop an antibody therapy that: i) targets ~ 30-50% of nonresponsive, "hot" tumors, ii) targets a largely unexplored cell regulator of tumor immunity and iii) works by removing local immunosuppression from "hot" tumors.
View Top Employees from BioGraph 55, Inc.Website | http://www.biograph55.com |
Revenue | $202000 |
Employees | 5 (3 on RocketReach) |
Founded | 2016 |
Address | 385 Oyster Point Blvd, South San Francisco, California 94080, US |
Phone | (888) 774-7472 |
Industry | Biotechnology, Pharmaceuticals, Drug Discovery, Healthcare |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies |
Looking for a particular BioGraph 55, Inc. employee's phone or email?
The BioGraph 55, Inc. annual revenue was $202000 in 2023.
3 people are employed at BioGraph 55, Inc..
BioGraph 55, Inc. is based in South San Francisco, California.
The NAICS codes for BioGraph 55, Inc. are [54, 541, 5417].
The SIC codes for BioGraph 55, Inc. are [28, 283].